USPTO trademark

TELL US WHERE IT HURTS

AllowedUSPTOWord markClass 3Class 5Class 10Class 11+1

"TELL US WHERE IT HURTS" is a word mark owned by Kobayashi Pharmaceutical Co., Ltd., filed at the USPTO on June 25, 2024. It has been allowed and covers classes 3, 5, 10, 11 and 25.

View Kobayashi Pharmaceutical Co., Ltd. portfolioGet this data via the API
Official USPTO record
TELL US WHERE IT HURTS trademark as filed
As filed with the USPTO
Status
Allowed
Since September 17, 2026
Filed
June 25, 2024
Registered
Not yet
Expires
Not recorded
Application no.
98617220
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
5 classes
Ownership

Who owns TELL US WHERE IT HURTS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Kobayashi Pharmaceutical Co., Ltd.

Osaka, Japan

322 trademarks in the portfolioView company

Representative

Carole Klinger

Fross Zelnick Lehrman & Zissu, P.C.

Goods and services

What the mark covers

The products and services TELL US WHERE IT HURTS is filed for, grouped by Nice class.

  • Cosmetics; non-medicated skin care preparations; lip balm; hair care preparations; hair coloring preparations; disposable wipes impregnated with chemicals or compounds for household use; bleaching preparations for the hair; breath freshening preparations for personal hygiene

  • Dietary and nutritional supplements; medicated skin care preparations; medicated lip balm; pharmaceutical preparations for the treatment of premenstrual syndrome and premenstrual tension; pharmaceutical preparations for pain relief; antiseptic and bactericidal ointment for use with artificial dentures; pharmaceutical preparations for relief from motion sickness; anti-fungal treatment preparations; toilet deodorizers; reagent paper for medical purposes; oiled paper for medical purposes; medical dressings; first aid dressings; breast-nursing pads; dietary supplements used for reducing water weight gain, bloating, swelling, and fatigue; diuretic pharmaceutical preparations; dietary supplements for urinary health; pharmaceutical preparations for the treatment of symptoms of psoriasis and seborrheic dermatitis; pharmaceutical preparations to treat headache; pharmaceutical preparations to treat nausea; anti-itch ointments, creams, and patches; plantar fasciitis medication; leg cramp medication; eye drops; medicated eye washes

  • Chemically-activated heating patches, sheets, packs, and pads for medical purposes; therapeutic devices using heat to provide relief from pain; chemically-activated cooling patches, sheets, packs, and pads for medical purposes; heating and cooling apparatus filled or coated with chemical substances for medical treatment; medical heating and cooling apparatus with storage for heating or cooling packs filled with chemical substances; support bandages; medical ice bags and packs; sanitary masks; therapeutic tapes for the prevention of snoring; anti-nausea wristbands; ice bag pillows for medical purposes; cooling patches for medical purposes

  • Chemically-activated heating patches, sheets, packs, and pads, not for medical purposes; chemically activated cooling patches, sheets, packs and, pads, not for medical purposes

  • Glove liners; glove liners and chemically-activated heating packets sold as a unit, other than for medical purposes; sock liners; sock liners and chemically-activated heating packets sold as a unit, other than for medical purposes; clothing, namely, neck gaiters, balaclavas, hand warmers, headbands, gloves, and mittens; headwear; socks; sleep masks

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 4 granted
  3. Sou extension 4 filed
  4. Sou teas extension received
  5. Notice of approval of extension request e-mailed
  6. Sou extension 3 granted
  7. Sou extension 3 filed
  8. Sou teas extension received
  9. Notice of approval of extension request e-mailed
  10. Sou extension 2 granted

10 earlier steps on the official record.

FAQ

About TELL US WHERE IT HURTS

Who owns the trademark "TELL US WHERE IT HURTS"?

The USPTO trademark "TELL US WHERE IT HURTS" (application 98617220) is owned by Kobayashi Pharmaceutical Co., Ltd.

What is the status of "TELL US WHERE IT HURTS"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull TELL US WHERE IT HURTS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2937-df7f-745e-a7fc-29ec63d25667
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2937-df7f-745e-a7fc-29ec63d25667",
  "object": "trademark",
  "mark_text": "TELL US WHERE IT HURTS",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "98617220",
  "filing_date": "2024-06-25",
  "nice_classes": [
    3,
    5,
    10,
    11,
    25
  ],
  "owners": [
    {
      "name": "Kobayashi Pharmaceutical Co., Ltd.",
      "entity_id": "ent_019eb6fb-2f8c-73bf-849f-97692615d268"
    }
  ]
}